• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

N-Hydroxypyrimidine-5-carboxamide (CAS No. 1334232-44-8): A Versatile Building Block in Medicinal Chemistry

The N-Hydroxypyrimidine-5-carboxamide (CAS No. 1334232-44-8) is an emerging heterocyclic compound gaining significant attention in pharmaceutical research and organic synthesis. This pyrimidine derivative serves as a crucial scaffold in drug discovery, particularly in the development of enzyme inhibitors and small molecule therapeutics. Its unique structural features make it valuable for creating bioactive compounds with potential applications in various therapeutic areas.

Recent trends in medicinal chemistry highlight the growing importance of N-Hydroxypyrimidine-5-carboxamide derivatives as privileged structures. Researchers are particularly interested in its role as a metal-binding pharmacophore, which enables interactions with various biological targets. The compound's hydrogen bond donor-acceptor properties make it especially valuable in designing targeted therapies, aligning with current interests in precision medicine approaches.

The physicochemical properties of N-Hydroxypyrimidine-5-carboxamide contribute to its pharmaceutical relevance. With a molecular weight of 139.11 g/mol and the presence of both hydroxyl and carboxamide functional groups, this compound exhibits balanced lipophilicity and water solubility—key factors in drug development. These characteristics address current industry challenges in optimizing drug-like properties while maintaining target engagement.

In synthetic chemistry, N-Hydroxypyrimidine-5-carboxamide serves as a versatile intermediate for constructing more complex molecular architectures. Its reactivity patterns enable diverse functional group transformations, making it valuable for combinatorial chemistry and library synthesis. The compound's stability under various reaction conditions has made it particularly useful in high-throughput screening applications, a hot topic in modern drug discovery.

The biological activity profile of N-Hydroxypyrimidine-5-carboxamide-containing compounds has shown promise in several therapeutic areas. Recent studies highlight its potential in developing anti-inflammatory agents and kinase inhibitors, addressing current demands for novel treatments in autoimmune diseases and oncology. The compound's ability to modulate protein-protein interactions makes it relevant to cutting-edge research in undruggable targets.

From a market perspective, the demand for N-Hydroxypyrimidine-5-carboxamide has been steadily increasing, driven by expanding research in small molecule drug discovery. Suppliers have reported growing interest from both academic institutions and pharmaceutical companies, particularly for applications in fragment-based drug design. The compound's commercial availability in various purity grades (typically 95-98%) supports its widespread use in research settings.

Quality control of N-Hydroxypyrimidine-5-carboxamide typically involves advanced analytical techniques, including HPLC, NMR, and mass spectrometry. These methods ensure the compound meets the stringent requirements of pharmaceutical research, where purity and structural integrity are paramount. Current good manufacturing practices (cGMP) for such research chemicals have become increasingly important in the supply chain.

The storage and handling of N-Hydroxypyrimidine-5-carboxamide require standard laboratory precautions. While not classified as hazardous, it should be stored in a cool, dry place, protected from light and moisture—common requirements for nitrogen-containing heterocycles. These handling protocols align with current laboratory safety standards and green chemistry principles.

Future research directions for N-Hydroxypyrimidine-5-carboxamide derivatives include exploring their potential in PROTAC technology and molecular glues, two rapidly growing areas in drug discovery. The compound's ability to participate in hydrogen bonding networks makes it particularly suitable for these applications, addressing current scientific interest in targeted protein degradation strategies.

In conclusion, N-Hydroxypyrimidine-5-carboxamide (CAS No. 1334232-44-8) represents a valuable chemical building block with diverse applications in medicinal chemistry and drug discovery. Its unique structural features, combined with favorable physicochemical properties, position it as an important tool for researchers developing next-generation therapeutics. As the pharmaceutical industry continues to focus on molecularly targeted therapies, the significance of such heterocyclic scaffolds is expected to grow substantially.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)